Oral D-galactose supplementation in PGM1-CDG.

Address: Hayward Genetics Center, Tulane University School of Medicine, New Orleans, Louisiana, USA.; Department of Neurology, Translational Metabolic Laboratory, Donders Institute for Brain, Cognition, and Behavior, Radboudumc, Nijmegen, The Netherlands.; Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.; Department of Pediatric Habilitation, Stavanger University Hospital, Stavanger, Norway.; Biochemical Diseases, Mater Children's Hospital, South, Brisbane, Queensland, Australia.; Screening and Metabolic Diagnostics Department, The Institute of Mother and Child, Warsaw, Poland.; Pediatric Cardiology, Bergisch Gladbacher Koln, Koln, Germany.; Genetics/Metabolics Service, Tawam Hospital, Al Ain, United Arab Emirates.; Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium.; Department of Anatomy, Radboud University Medical Centre, Nijmegen, The Netherlands.; Washington State University College of Pharmacy, Spokane, Washington, USA.; Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.; University Lille, CNRS, UMR 8576-UGSF-Unité de Glycobiologie Structurale et Fonctionnelle, Lille, France.; Centre for Organismal Studies (COS), University of Heidelberg, Heidelberg, Germany.; Division of Endocrinology and Diabetes, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Palmieri Metabolic Disease Laboratory, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Center for Child and Adolescent Medicine, Kinderheilkunde I, University of Heidelberg, Heidelberg, Germany.; Hayward Genetics Center, Tulane University School of Medicine, New Orleans, Louisiana, USA.; Department of Anatomy, Radboud University Medical Centre, Nijmegen, The Netherlands.